The FDA recently cleared this device for sale in the U.S. Research shows it can improve moderate to severe depression ...

The FDA has approved Flow, a prescription home-use cranial electrotherapy stimulation device, for treating moderate to severe ...

A small study shows cognitive improvements in patients with AD following treatment with an in-home gamma sensory stimulation ...

Flow is a transcranial direct current stimulation device that delivers low-intensity direct electrical current to specific areas of the brain through electrodes that are placed on the scalp.

Patients can use the headset themselves in their homes to counteract moderate to severe depression, with what the FDA says are “modest” results.

A noninvasive, home-based brain treatment with transcranial direct current stimulation (tDCS) can reduce pain severity, improve pain-related disability, and enhance endogenous pain modulation in women ...

Please provide your email address to receive an email when new articles are posted on . High-definition transcranial direct current stimulation was well tolerated with mild adverse effects. The ...

The U.S. Food and Drug Administration cleared Flow Neuroscience’s at-home electrical stimulation headset for adults with moderate-to-severe depression A trial of 174 people found the device led to ...